You can buy or sell Moderna and other stocks, options, ETFs, and crypto commission-free!
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. Read More The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Moderna Coronavirus Vaccine Phase 2 Trials Could Start In Spring, Chairman Says
The second phase of the clinical trials of the novel coronavirus (COVID-19) vaccine of Moderna Inc. (NASDAQ: MRNA) could begin in spring, the biotechnology comp
Moderna Coronavirus Vaccine Clinical Trials Are 'On Track,' White House Task Force's Fauci Says
The clinical trials of Moderna Inc.'s (NASDAQ: MRNA) novel coronavirus (COVID-19) vaccine are "on track," according to National Institute of Allergy and Infecti
— per share
Expected May 6, Pre-Market